Phase 1-2a multicenter dose-escalation study of Ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome

Azra Raza*, Naomi Galili, Natalie Callander, Leonel Ochoa, Lawrence Piro, Peter Emanuel, Stephanie Williams, Howard Burris, Stefan Faderl, Zeev Estrov, Peter Curtin, Richard A. Larson, James G. Keck, Marsha Jones, Lisa Meng, Gail L. Brown

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1-2a multicenter dose-escalation study of Ezatiostat hydrochloride liposomes for injection (Telintra®, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences